Sexually transmitted infections, prostatitis, ejaculation frequency, and the odds of lower urinary tract symptoms

American Journal of Epidemiology

Volumn 162, Issue 9, 2005, Pages 898-906

  Sutcliffe, Siobhan ^a   Giovannucci, Edward ^b,c   De Marzo, Angelo M ^d   Willett, Walter C ^b,c   Platz, Elizabeth A ^a,d  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Ejaculation; Gonorrhea; Prostatic hyperplasia; Prostatitis; Sexually transmitted diseases; Syphilis

Indexed keywords

HEALTH AND DISEASE;

ADULT; AGED; ANAMNESIS; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; EJACULATION; EPIDEMIOLOGICAL DATA; GONORRHEA; HUMAN; MALE; PATIENT INFORMATION; PREVALENCE; PROSTATE HYPERTROPHY; PROSTATE SURGERY; PROSTATISM; QUESTIONNAIRE; SCORING SYSTEM; SEXUALLY TRANSMITTED DISEASE; URETHRA DISEASE; UROGENITAL TRACT INFECTION;

ADULT; AGE FACTORS; AGED; CASE-CONTROL STUDIES; EJACULATION; FOLLOW-UP STUDIES; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; PROSPECTIVE STUDIES; PROSTATIC HYPERPLASIA; PROSTATITIS; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASES; UNITED STATES; URINATION DISORDERS;

EID: 27544471341     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwi299     Document Type: Article

References (24)

1. Garraway WM, Collins GN, Lee RJ. High prevalence of benign prostatic hypertrophy in the community. Lancet 1991;338:469-71.
2. Berry SJ, Coffey DS, Walsh PC, et al. The development of human benign prostatic hyperplasia with age. J Urol 1984;132:474-9.
3. Lepor H. Prostatic diseases. Philadelphia, PA: WB Saunders Company, 2000.
4. Pelouze PS. Gonorrhea in the male and female: a book for practitioners. Philadelphia, PA: WB Saunders Company, 1935.
5. Moore RA. Benign hypertrophy of the prostate: a morphological study. J Urol 1943;50:680-710.
6. Di Silverio F, Gentile V, De Matteis A, et al. Distribution of inflammation, pre-malignant lesions, incidental carcinoma in histologically confirmed benign prostatic hyperplasia: a retrospective analysis. Eur Urol 2003;43:164-75.
7. Nickel JC, Downey J, Young I, et al. Asymptomatic inflammation and/or infection in benign prostatic hyperplasia. BJU Int 1999;84:976-81.
8. Kohnen PW, Drach GW. Patterns of inflammation in prostatic hyperplasia: a histologic and bacteriologic study. J Urol 1979;121:755-60.
9. Anjum I, Ahmed M, Azzopardi A, et al. Prostatic infarction/ infection in acute urinary retention secondary to benign prostatic hyperplasia. J Urol 1998;160:792-3.
10. Kessler OJ, Keisari Y, Servadio C, et al. Role of chronic inflammation in the promotion of prostatic hyperplasia in rats. J Urol 1998;159:1049-53.
11. Robinette CL. Sex-hormone-induced inflammation and fibromuscular proliferation in the rat lateral prostate. Prostate 1988; 12:271-86.
12. Isaacs JT. Prostatic structure and function in relation to the etiology of prostatic cancer. Prostate 1983;4:351-66.
13. Steele R, Lees RE, Kraus AS, et al. Sexual factors in the epidemiology of cancer of the prostate. J Chronic Dis 1971;24:29-37.
14. Araki H, Watanabe H, Mishina T, et al. High-risk group for benign prostatic hypertrophy. Prostate 1983;4:253-64.
15. Oishi K, Okada K, Yoshida O, et al. A case-control study of prostatic cancer in Kyoto, Japan: sexual risk factors. Prostate 1990;17:269-79.
16. Signorello LB, Tzonou A, Lagiou P, et al. The epidemiology of benign prostatic hyperplasia: a study in Greece. BJU Int 1999;84:286-91.
17. Lees RE, Steele R, Wardle D. Arsenic, syphilis, and cancer of the prostate. J Epidemiol Community Health 1985;39:227-30.
18. Joseph MA, Harlow SD, Wei JT, et al. Risk factors for lower urinary tract symptoms in a population-based sample of African-American men. Am J Epidemiol 2003;157:906-14.
19. Collins MM, Meigs JB, Barry MJ, et al. Prevalence and correlates of prostatitis in the Health Professionals Follow-up Study cohort. J Urol 2002;167:1363-6.
20. Giovannucci E, Rimm EB, Chute CG, et al. Obesity and benign prostatic hyperplasia. Am J Epidemiol 1994;140:989-1002.
21. Barry MJ, Fowler FJJ, O'Leary MP, et al. The American Urological Association symptom index for benign prostatic hyperplasia. J Urol 1992;148:1549-57.
22. Gleason PE, Jones JA, Regan JS, et al. Platelet derived growth factor (PDGF), androgens and inflammation: possible etiologic factors in the development of prostatic hyperplasia. J Urol 1993;149:1586-92.
23. Feneley MR, Span PN, Schalken JA, et al. A prospective randomized trial evaluating tissue effects of finasteride therapy in benign prostatic hyperplasia. Prostate Cancer Prostatic Dis 1999;2:277-81.
24. Leitzmann MF, Platz EA, Stampfer MJ, et al. Ejaculation frequency and subsequent risk of prostate cancer. JAMA 2004;291:1578-86.